Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

Acetaminophen-induced differentiation of human breast cancer stem cells and inhibition of tumor xenograft growth in mice

(2011) Masaya Takehara et al.   BIOCHEMICAL PHARMACOLOGY

Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen

(2011) Bruno M Simões et al.   Future Oncology

Reduction of the putative CD44+CD24− breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047

(2010) Helena Cirenajwis et al.   ANTI-CANCER DRUGS

Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice

(2010) Soichiro Murata et al.   CANCER SCIENCE

Retinoid signaling regulates breast cancer stem cell differentiation

(2010) Christophe Ginestier et al.   CELL CYCLE

Heat shock proteins in breast cancer progression–A suitable case for treatment?

(2010) Stuart K. Calderwood   INTERNATIONAL JOURNAL OF HYPERTHERMIA

All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells

(2010) Ruo-Jing Li et al.   JOURNAL OF CONTROLLED RELEASE

Silencing HSF1 by short hairpin RNA decreases cell proliferation and enhances sensitivity to hyperthermia in human melanoma cell lines

(2010) Yoshitaka Nakamura et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Role of Lef1 in sustaining self-renewal in mouse embryonic stem cells

(2010) Chen Huang et al.   Journal of Genetics and Genomics

Inhibition of Fatty Acid Synthase Suppresses c-Met Receptor Kinase and Induces Apoptosis in Diffuse Large B-Cell Lymphoma

(2010) S. Uddin et al.   MOLECULAR CANCER THERAPEUTICS

Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways

(2010) Naoko Takebe et al.   Nature Reviews Clinical Oncology

Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis

(2010) L Meng et al.   ONCOGENE

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition

(2010) L D Roy et al.   ONCOGENE

MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells

(2009) Shawn P. Fessler et al.   BREAST CANCER RESEARCH AND TREATMENT

Inhibiting the transcription factor HSF1 as an anticancer strategy

(2009) Luke Whitesell et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus

(2009) Francine Walker et al.   HUMAN PATHOLOGY

Treatment Resistance in Stem Cells and Breast Cancer

(2009) Bhuvanesh Dave et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Inhibition of Fatty Acid Synthase by Orlistat Accelerates Gastric Tumor Cell Apoptosis in Culture and Increases Survival Rates in Gastric Tumor Bearing Mice In Vivo

(2009) Shawn Dowling et al.   LIPIDS

DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy

(2009) G. Frosina   MOLECULAR CANCER RESEARCH

MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable Decoy

(2009) Sara K. Lindén et al.   PLoS Pathogens

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion

(2008) H Korkaya et al.   ONCOGENE

Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours

(2008) Virginia Tirino et al.   PLoS One

Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer

(2008) Gabriella Mariani et al.   Nature clinical practice. Oncology